Investment Rating - The report assigns a Neutral rating to Aier Eye Hospital with a 12-month target price of Rmb14, indicating a potential upside of 12.9% from the current price of Rmb12.4 [10][8]. Core Insights - Aier Eye Hospital is experiencing improvements in refractive surgery pricing due to new technologies, with a forecast of double-digit revenue growth for 2025 [2][7]. - The company anticipates a recovery in cataract surgery revenue growth to double digits in the second half of 2025, following price cuts of approximately 8-10% since the second half of 2024 [9][7]. - The overall ophthalmology market in China is expected to grow at a 12% CAGR from 2020 to 2030, driven by increased service upgrades and market penetration [7]. Summary by Sections Recent Trends - Growth in refractive surgeries slowed in April and May after a busy first quarter, but June showed improvement due to an increase in average selling prices (ASP) from new technologies [3]. - Cataract surgeries faced volume declines due to tightening reimbursement policies, while optometry performance remained moderate [3]. Refractive Surgery Pricing - New technologies such as SMILE 4.0 and SMILE pro have been launched, with SMILE 4.0 contributing 12% of refractive surgery revenue in Q1 2025 [3][6]. - The ASP for SMILE 4.0 is around Rmb18,800, with approximately 100 installations [3]. Cataract Surgery Outlook - The company expects cataract surgery revenue growth to recover to double digits in H2 2025, as the lower prices from H2 2024 are now reflected [9]. - Premium cataract surgeries accounted for 45%-50% of total cataract surgeries as of Q1 2025, with 15% of revenue coming from femtosecond laser-assisted surgeries [9]. Optometry Services - Recent pricing pressure on OK lenses was noted, particularly after public hospitals in Beijing reduced prices by 50% [9]. - The annualized cost for OK lenses is around Rmb10,000, while defocal lenses cost only Rmb2,000 to Rmb3,000 [9]. Overseas Expansion - Aier Eye Hospital is focusing on expanding its presence in South America [9].

Investment Rating - The report does not provide a specific investment rating for Conant Optical (2276.HK) as it is categorized as "Not Covered" [1]. Core Insights - Conant Optical is expanding its business from traditional spectacle lenses to AI/AR glasses, anticipating sustained growth in its core business and increased demand for AI/AR glasses due to their higher dollar content and specific client requirements [1][2]. - The company is positioned to benefit from the growing AI/AR glasses market, with expectations of a 56% CAGR in shipments in China from 2024 to 2030, reaching 7 million units by 2030 [2]. - Conant's customized lenses for AI/AR glasses are designed to be lighter and thinner, with a significant increase in average selling price (ASP) compared to traditional lenses [4]. Summary by Sections Company Profile - Conant Optical is a leading resin lenses manufacturer in China, with 44% of its revenues from standardized lenses, 37% from functional lenses, and 19% from customized lenses, which have a higher gross margin [3]. - The company operates in 90 countries and ranks among the top 10 resin lenses manufacturers globally by revenue [3]. Market Outlook - Management expresses optimism about the AI/AR glasses market's growth potential, indicating that Conant will be a key beneficiary due to its customized lens solutions for both global and local clients [8]. - The company plans to enhance its market presence by partnering with offline stores in China to facilitate the lens ordering process for consumers [8]. Production Capabilities - Conant has demonstrated strong mass production capabilities, allowing it to produce millions of customized lenses quickly, supported by its precision manufacturing skills [7]. - The company is expanding its production capacity with a new plant in Thailand expected to commence operations in 2026 [7].

Investment Rating - The report maintains a neutral asset allocation stance while focusing on diversification across regions and styles [3]. Core Insights - Increased expectations of a more dovish Federal Reserve and de-escalation of geopolitical tensions have created a favorable "Goldilocks" environment for markets, supporting growth pricing across various assets [1][2]. - The report highlights a broad geographical bullish growth repricing, with equities outperforming bonds and cyclicals outperforming defensives [1]. - Consensus EPS revisions have turned less negative recently, with positive revisions noted for the US market, indicating improved expectations for equity fundamentals [2]. Summary by Sections Market Conditions - The report indicates that markets are pricing in a more dovish Fed, with expectations for a rate cut brought forward to September and a reduced terminal rate forecast of 3-3.25% [1][7]. - The labor market data expected this Thursday is deemed critical for sustaining positive momentum, with economists forecasting 85k for non-farm payrolls, below the consensus of +113k [1]. Earnings Outlook - The upcoming Q2 earnings season is highlighted as a key focus, with a relatively low bar for EPS growth set at 4%, down from 12% in Q1, and insights expected on corporate adjustments to increased tariff rates [2]. Asset Allocation - The report suggests that reverse dispersion trades may be attractive as a macro hedge against potential growth deterioration over the summer [2]. - Recommendations include option hedges and specific strategies such as USD HY puts/CDS payers to hedge against stagflationary shocks [6]. Performance Metrics - The report provides forecasts for various asset classes, indicating expected total returns and downside risks for equities and bonds over different time horizons [18]. - The S&P 500 is projected to have a total return of -4.1% over 3 months, with a potential upside of 6.6% over 12 months [18]. Risk Appetite - The report notes a rebound in the Risk Appetite Indicator to 0.3, reflecting increased risk appetite among investors [1][26]. - Implied equity correlations have been falling, indicating expectations of more dispersion in the earnings season and a fading macro risk environment [2][15].

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The report highlights five key themes impacting the market, including macroeconomic factors, currency dynamics, oil market conditions, and tariff developments [1][2][5][20][29] Summary by Sections Macroeconomic Insights - The UK is positioned as a higher-growth, higher-inflation jurisdiction compared to G10 peers, with terminal rates likely settling 100-200 basis points above Europe [2][3] - Business confidence in the UK is at multi-month highs, and there is a deep sovereign bond market with long-term investors under-invested [2][3] Currency Dynamics - The USD may weaken further due to a dovish tilt from the Fed, especially if upcoming labor market data shows weakness [5][6] - The Euro area is experiencing equity inflows, which may lead to a stronger Euro, although the pace could slow if there are no compelling reasons to reallocate from the US [7][8] - The JPY is expected to maintain demand due to recession risks and reduced appeal of US assets, while the INR may lag in appreciation compared to other Asian currencies [9][13] Oil Market Analysis - The risk premium in oil prices has significantly decreased, dropping from over $15 per barrel to just a few dollars, as geopolitical risks have lessened [20][21] - The report forecasts Brent crude oil prices to decline from the current high 60s to around $60 in Q4 and mid-50s by 2026, driven by oversupply [23][24] - Global oil inventories have increased by approximately 1.3 million barrels per day over the last 90 days, supporting the forecast of an oversupplied market [27][28] Tariff Developments - The July 9 tariff deadline is likely to be pushed out, with potential for sectoral tariffs rather than broad increases [29][30] - The report suggests that specific sectors, such as semiconductors and pharmaceuticals, may face targeted tariffs, but the timing remains uncertain [35][36]

Investment Rating - The report does not explicitly provide an investment rating for the industry or the specific company, SenseTime Core Insights - The management of SenseTime is optimistic about the increasing demand for generative AI solutions from enterprise clients, emphasizing their capability to deliver a comprehensive one-stop solution that includes infrastructure, software migration services, foundational models, and applications [1][4][7] - SenseTime's generative AI products have shown triple-digit year-over-year growth in 2024, contributing 64% to the total revenue, indicating strong market traction [4][8] - The company is also expanding its generative AI applications, targeting various sectors including productivity tools and interactive AI tools, with significant engagement metrics reported [8][9] Summary by Sections Generative AI Solutions - SenseTime is positioned to provide a complete generative AI solution, from infrastructure to foundational models and applications, which is crucial for enterprise clients looking to implement AI effectively [1][4][7] - The company has developed an in-house large-scale AI data center (AIDC) in Shanghai, enhancing its operational capabilities and software migration processes [7] Market Engagement - SenseTime's generative AI applications have penetrated major enterprises such as Kingsoft Office, China Mobile, and Lenovo, with daily API calls exceeding 3.5 billion, showcasing the high demand for their tools [8] - The company has also launched multiple AI interactive tools, achieving high engagement and conversion rates, indicating successful commercialization strategies [8] Automotive Solutions - In 2024, SenseTime's automotive solutions empowered 42 new car models, and the company is collaborating with major automotive manufacturers to deploy advanced AI functionalities [9] - The expectation is set for mass production of their intelligent driving solutions on NVIDIA's Thor platform by the end of 2025, reflecting a strong pipeline for future growth in the automotive sector [9]

Investment Rating - The investment rating for China Resources Pharmaceuticals is Neutral with a 12-month price target of HK$6.17, representing an upside potential of 18.8% from the current price of HK$5.19 [8][29]. Core Insights - The company is experiencing soft growth in the first half of the year, leading management to lower previous guidance of double-digit year-on-year sales growth for 2025, pending a recovery in the second half [1][2]. - The distribution business is facing challenges due to a tough industry environment, and there are no clear signals of growth recovery as the national medical reimbursement fund remains tight [2][3]. - Cash collection is under pressure, with hospitals' financial positions still strained, resulting in delayed payments for non-VBP products despite some acceleration in cash collection for VBP products [3]. Summary by Sections Financial Performance - Revenue for 2025 is projected to be HK$271.5 billion, with a 5-year EPS CAGR of 10% for the manufacturing business and 5% for the distribution business [7]. - The company’s market cap is HK$32.6 billion, with an enterprise value of HK$133.8 billion [8]. Business Segments - The manufacturing business is valued at HK$31.4 billion, while the distribution business is valued at HK$4.1 billion [7]. - Specific challenges include slower growth for Sanjiu due to a high base, pressure on Boya from albumin VBP, and a softer growth trajectory for plasma collection [2]. Cash Management - To alleviate cash pressure, the company is managing its cash cycle actively, including de-prioritizing high-risk regions for receivables [3].

Investment Ratings - The report provides a "Buy" rating for First Quantum Minerals and Ero Copper, while Capstone Copper, Antofagasta, and Codelco are rated as "Neutral" [9][12][18][21][26][35]. Core Insights - The copper market is experiencing ongoing cyclical and structural bullishness regarding supply and demand dynamics [2]. - The consensus incentive price for copper is projected to be above $4.5/lb, with some major projects requiring prices between $4.75-$5/lb to incentivize capital returns [2][22][45]. - Cost inflation in the industry has peaked, and the regulatory environment is improving, which may support future project developments [2][22]. Summary by Company Antofagasta - Antofagasta is a pure-play copper producer with a market cap of $24.7 billion, targeting copper production of approximately 750ktpa in 2024 [9]. - The company is focused on brownfield project development, with major growth projects at Centinela and Los Pelambres progressing on schedule [10]. - The 2025 copper production guidance is set at 660-700kt, with net cash costs expected between $1.45-1.65/lb [11]. Capstone Copper - Capstone Copper, with a market cap of $4.7 billion, has a production guidance of 220kt-255kt for 2025 [14]. - The company is focusing on deleveraging and smaller expansion projects before a significant growth phase with the Santo Domingo project [15]. - The management anticipates a financing gap of $200-300 million for the Santo Domingo project, which they aim to address through internal cash flow generation [16]. Codelco - Codelco, a state-owned enterprise, aims for a copper production target of 1.7Mt by 2030, with significant projects at Chuquicamata and El Teniente [21][24]. - The company is exploring public-private partnerships to enhance copper production and smelting capacity [23]. - Codelco's capital allocation strategy includes a focus on internal cash flow to fund growth, with an available capital of $4 billion [25]. Ero Copper - Ero Copper, with a market cap of $1.8 billion, is expected to reach commercial production at its Tucumã operation soon, with a production capacity of 85ktpa of copper [26]. - The company aims to maintain C1 cash costs below $2.00/lb, leveraging high-grade zones at its Caraíba mine [27]. - Ero Copper has a 12-month price target of $18.0 based on DCF methodology [28]. First Quantum Minerals - First Quantum Minerals, with a market cap of $14.7 billion, has a production capacity of 820ktpa and is focused on strong physical demand and tight inventories [30]. - The company is excited about the Furnas project, which is expected to deliver high-grade deposits [31]. - First Quantum has a 12-month target price of C$22.0/share based on an EV/EBITDA multiple-based valuation [35]. Foran Mining - Foran Mining is the only single-asset developer constructing a copper mine in North America, targeting commercial production by mid-2026 [37]. - The company has cleared permitting and funding hurdles, with surface construction approximately 35% complete [38]. Freeport-McMoran - Freeport-McMoran, the largest publicly traded pure-play copper producer, is focused on improving efficiencies and reducing costs [39]. - The company has a large project pipeline representing an annual capacity of 2.5 billion lbs [40]. Hudbay Minerals - Hudbay Minerals has a market cap of $4.2 billion and is advancing its Copper World project, which is fully permitted for 85ktpa production [41]. - The company is optimistic about the regulatory environment in the US and Peru, which supports its project developments [42]. Teck Resources - Teck Resources is focused on responsible growth and value creation, with a strong portfolio of world-class assets [44]. - The company believes that copper incentive prices will need to be above $5/lb to generate adequate returns [45]. Vale Base Metals - Vale Base Metals is undergoing significant restructuring, with a focus on maximizing brownfield opportunities and improving project economics [48]. - The company aims for a copper production guidance of 700kt by 2035, with potential to exceed this figure [48].

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - Onshore clients have become less bearish on China's near-term growth outlook, with expectations for RMB appreciation against USD and a belief that exports may be more resilient than previously feared [1][2] - Clients express skepticism regarding incremental policy easing, viewing the current easing mode as reactive rather than preemptive, and anticipate further fiscal expansion in H2 to stabilize growth [2][10] - Concerns about US-China tariff negotiations remain, with clients expressing low conviction in potential outcomes and expecting tariffs to remain at current levels for the rest of the year [3][8] Summary by Sections 1. Near-term Growth Outlook - Onshore clients have adjusted their views to be less negative about China's growth, noting resilience in macro data and some bargaining power in trade negotiations [2] - Clients believe that solid GDP growth in H1 may reduce the urgency for significant policy stimulus, although further fiscal measures are still deemed necessary [2][10] 2. US-China Tariff Relations - Clients show low conviction regarding the future of US-China tariffs, with expectations that current tariffs (around 39%) may persist [3][8] - The complexity of potential trade deals is acknowledged, with clients anticipating that any agreement would be more complicated than previous arrangements [3] 3. Exports, Consumption, and Inflation - While strong exports are not seen as sustainable, clients expect some resilience in H2, with concerns about the property sector and PPI deflation remaining [9] - The report forecasts CPI at 0.0% and PPI at -2.4% for 2025, with expectations for home prices in top-tier cities to stabilize by H2 2026 [9] 4. Triggers for Policy Easing - Clients identify potential triggers for policy easing, including rising youth unemployment, falling home prices, and significant declines in durable goods sales [10] - There is a belief that some pro-growth policies may not yet be fully priced in for the remainder of the year [10] 5. RMB and Interest Rates - Onshore clients expect further RMB appreciation against USD, with forecasts of USDCNY at 7.1/7.0/6.9 over the next 3, 6, and 12 months [12] - Clients anticipate that China rates will remain low for an extended period, with a wide interest rate differential between China and the US [12] 6. Onshore vs Offshore Client Perspectives - Differences in perspectives are noted, with onshore clients focusing more on stabilizing the property sector and improving local policy implementation, while offshore clients emphasize signals from policy meetings [13] - Both groups see more upside than downside for China equity and RMB, viewing Q3 as a critical period for market developments [13]

25 June 2025 | 8:38PM CST TSMC (2330.TW) Growth outlook further reinforced by easing concern on AI order cuts and growing CoWoS adoption; reiterate Buy (on CL); TP to NT$1,210 | 2330.TW | 12m Price Target: NT$1,210.00 | Price: NT$1,070.00 | Upside: 13.1% | | --- | --- | --- | --- | | TSM | 12m Price Target: $242.00 | Price: $220.09 | Upside: 10.0% | We are raising our earnings forecast for TSMC by 2-6% for 2025-2027E as we raise our 1) wafer revenue forecast for 3nm/5nm, partially to factor in our easing co ...

Investment Rating - The report initiates coverage of Circle Internet Group (CRCL) with a Neutral rating and a 12-month price target of $83, indicating a potential downside of 54% from the current price of $180.43 [1][13][29] Core Insights - CRCL is positioned as a unique asset in the crypto ecosystem, being the only pure play crypto-native company that can expand into large existing fiat markets without the direct price volatility associated with crypto trading [1][27] - The main product, USDC, is a stablecoin designed to represent USD on the blockchain, with a projected 40% compound annual growth rate (CAGR) in USDC supply from 2024 to 2027 [2][27] - The report anticipates a 26% revenue CAGR and a 37% adjusted earnings per share (EPS) CAGR for CRCL from 2024 to 2027, driven by market share gains and the expansion of the crypto ecosystem [2][27] Summary by Sections Business Overview - CRCL issues and manages USDC, which has a market cap of $61 billion as of June 2025, representing 25% of the total stablecoin market cap [30][31] - The company has seen significant growth in USDC, with a market cap increase from $25 billion at the end of 2023 to $61 billion by mid-2025 [30][31] Financial Projections - Revenue is projected to grow from $658.9 million in 2024 to $1.324 billion by 2027, with net income expected to rise from $214.7 million to $550.9 million in the same period [4][10] - The adjusted pre-tax margin is forecasted to increase by approximately 11.5 percentage points to 53% by 2027, benefiting from a largely fixed cost base [2][27] Market Dynamics - The report highlights the potential for USDC to penetrate new total addressable markets (TAMs), particularly in cross-border payments and fiat trading, which could provide significant upside [3][28] - The stablecoin market is expected to grow from approximately $240 billion to over $1 trillion in the next 3-5 years, with a significant portion of clients anticipating this growth [24][28] Competitive Positioning - CRCL's growth is supported by ongoing global stablecoin legislation that favors compliant stablecoins like USDC, alongside strategic partnerships that enhance market share [2][27] - The company is positioned to benefit from a strong regulatory framework, which is expected to catalyze long-term growth in the stablecoin sector [27][29]